Prescribing of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) increased sharply in Ontario between 2015 and 2023, with particularly rapid growth after 2020 and disproportionate increases among women and adults aged 18…
After a false start with the Dengvaxia® dengue fever vaccine produced in France, and an unresolved dispute with the U.S. FDA over the authorization of a second-generation QDENGA® vaccine made in Japan, many…
A new analysis from the Centers for Disease Control and Prevention (CDC) finds that the 2024-25 COVID-19 vaccine substantially reduced the risk of emergency department (ED) and urgent care (UC) visits among US children and adolescents. The…
A new study from investigators at Harvard and Beth Israel Deaconess Medical Center sheds light on why some people never fully recover from COVID-19.
In research that analyzed blood samples from more than 140 participants, scientists led by…
Scientific innovation and collaboration were central themes at the 2025 EndoRISE Fall Forum, hosted by The Jackson Laboratory (JAX) on Monday. The statewide event, dedicated to advancing awareness, advocacy, and innovation in…
A systematic review and meta-analysis recently published in the American Journal of Ophthalmology assessed the accuracy of EyeArt for fundus-based detection of diabetic retinopathy (DR).
Although early detection of DR…
Enjaymo (sutimlimab-jome) remains safe to use over the long term, according to new real-world data from adults with primary or secondary cold agglutinin disease (CAD) who have been taking the approved medication for an average of more than two…
Infertility is never just a diagnosis—it’s a deeply personal journey. For Dr. Yaron Goikhman, an obstetrician-gynecologist and reproductive medicine specialist, this journey became personal in 2021 when he and his wife decided to pursue in…
